Develops drugs for gastrointestinal and rare diseases.
Jun 2026Revenue $389M/yrExpenses $155M/yr
No trend
Figures by year
Is Ironwood Pharmaceuticals profitable?
Yes. In the 12 months to Jun 2026, revenue was $389M and expenses $155M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $296M | $198M | $98.5M |
| Dec 2024 | $351M | $258M | $93.1M |
| Dec 2023 | $443M | $1.39B | −$945M |
| Dec 2022 | $411M | $160M | $250M |
| Dec 2021 | $414M | $181M | $232M |
| Dec 2020 | $390M | $247M | $143M |
| Dec 2019 | $428M | $308M | $120M |
| Dec 2018 | $347M | $497M | −$151M |
| Dec 2017 | $298M | $314M | −$15.4M |
| Dec 2016 | $274M | $326M | −$51.9M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.